Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NASDAQ:ISO

IsoPlexis - ISO Stock Forecast, Price & News

$1.42
-0.06 (-4.06%)
(As of 11/25/2022 08:57 PM ET)
Add
Compare
Today's Range
$1.35
$1.42
50-Day Range
$1.35
$1.95
52-Week Range
$1.33
$14.49
Volume
500 shs
Average Volume
72,773 shs
Market Capitalization
$56.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.75

IsoPlexis MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
164.1% Upside
$3.75 Price Target
Short Interest
Healthy
2.00% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$38,756 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($2.18) to ($1.36) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.43 out of 5 stars

Medical Sector

210th out of 1,044 stocks

Analytical Instruments Industry

7th out of 28 stocks

ISO stock logo

About IsoPlexis (NASDAQ:ISO) Stock

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.

Receive ISO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IsoPlexis and its competitors with MarketBeat's FREE daily newsletter.

ISO Stock News Headlines

IsoPlexis Third Quarter 2022 Earnings: Misses Expectations
IsoPlexis Reports Third Quarter 2022 Financial Results
IsoPlexis to Participate in Upcoming Investor Conferences
IsoPlexis Corp. Q2 sales decline
IsoPlexis Reports Second Quarter 2022 Financial Results
IsoPlexis Corp - Stock Chart
See More Headlines
Receive ISO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IsoPlexis and its competitors with MarketBeat's FREE daily newsletter.

ISO Company Calendar

Last Earnings
11/10/2021
Today
11/27/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/01/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ISO
Fax
N/A
Employees
459
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.75
High Stock Price Forecast
$5.00
Low Stock Price Forecast
$2.50
Forecasted Upside/Downside
+164.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-81,570,000.00
Net Margins
-517.60%
Pretax Margin
-517.60%

Debt

Sales & Book Value

Annual Sales
$17.26 million
Book Value
$3.65 per share

Miscellaneous

Free Float
37,043,000
Market Cap
$56.20 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Sean Mackay (Age 40)
    Co-Founder, CEO, Pres & Director
    Comp: $635.55k
  • Mr. John R. Strahley CPA (Age 55)
    Chief Financial Officer
    Comp: $444.11k
  • Mr. Rong Fan
    Co-Founder & Chairman of Scientific Advisory Board
  • Mr. Jon Chen
    VP of Technology & Co-Founder
  • Mr. Anthony Catalano
    Sr. VP of Operations
  • Mr. Rajesh T. Khakhar
    VP of Fin. & Principal Accounting Officer
  • Ms. Jing Zhou M.D. (Age 52)
    Ph.D., Chief Scientific Officer
  • Mr. Richard W. Rew II (Age 54)
    Sr. VP, Gen. Counsel & Sec.
  • Ms. Verna Siu
    Sr. VP of Sales Operations
  • Ms. Carrie Carter
    Sr. VP of People Operations













ISO Stock - Frequently Asked Questions

Should I buy or sell IsoPlexis stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IsoPlexis in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ISO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ISO, but not buy additional shares or sell existing shares.
View ISO analyst ratings
or view top-rated stocks.

What is IsoPlexis' stock price forecast for 2023?

2 analysts have issued twelve-month price objectives for IsoPlexis' shares. Their ISO share price forecasts range from $2.50 to $5.00. On average, they anticipate the company's stock price to reach $3.75 in the next year. This suggests a possible upside of 164.1% from the stock's current price.
View analysts price targets for ISO
or view top-rated stocks among Wall Street analysts.

How have ISO shares performed in 2022?

IsoPlexis' stock was trading at $9.19 on January 1st, 2022. Since then, ISO stock has decreased by 84.5% and is now trading at $1.42.
View the best growth stocks for 2022 here
.

When is IsoPlexis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 1st 2023.
View our ISO earnings forecast
.

How were IsoPlexis' earnings last quarter?

IsoPlexis Co. (NASDAQ:ISO) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($10.66) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.79) by $9.87. The business had revenue of $4.19 million for the quarter, compared to analyst estimates of $3.79 million. IsoPlexis had a negative net margin of 517.60% and a negative trailing twelve-month return on equity of 89.63%.

What guidance has IsoPlexis issued on next quarter's earnings?

IsoPlexis issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $19.16 million-$19.85 million, compared to the consensus revenue estimate of $20.21 million.

When did IsoPlexis IPO?

(ISO) raised $125 million in an initial public offering (IPO) on Friday, October 8th 2021. The company issued 8,333,000 shares at $14.00-$16.00 per share.

What is IsoPlexis' stock symbol?

IsoPlexis trades on the NASDAQ under the ticker symbol "ISO."

Who are IsoPlexis' major shareholders?

IsoPlexis' stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.72%) and Vanguard Group Inc. (1.26%). Insiders that own company stock include John Strahley, Nachum Shamir, Richard W Rew II and Sean Mackay.
View institutional ownership trends
.

How do I buy shares of IsoPlexis?

Shares of ISO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IsoPlexis' stock price today?

One share of ISO stock can currently be purchased for approximately $1.42.

How much money does IsoPlexis make?

IsoPlexis (NASDAQ:ISO) has a market capitalization of $56.20 million and generates $17.26 million in revenue each year.

How many employees does IsoPlexis have?

The company employs 459 workers across the globe.

How can I contact IsoPlexis?

IsoPlexis' mailing address is 35 NE INDUSTRIAL ROAD, BRANFORD CT, 06405. The official website for the company is isoplexis.com. The company can be reached via phone at 203-208-4111 or via email at investors@isoplexis.com.

This page (NASDAQ:ISO) was last updated on 11/28/2022 by MarketBeat.com Staff